← Back

Healthcare Co Ltd

Healthcare Co.,Ltd. research, develops, produces, and sells memory foam mattresses, pillows, pillows, sofas, electric beds, and other home products in China. It sells its products under the MLILY, MLILY Zero Pressure Room, and NISCO brand names. The company was formerly known as Nantong Hengkang Sponge Products Co., Ltd. Healthcare Co., Ltd. was founded in 2003 and is headquartered in Rugao, China.

Price · split & dividend adjusted
News & notes moving 603313.CG
603313.CG

Multiple A-share companies announce receipt of US tariff refunds

Recently, multiple A-share listed companies have announced receipt of US tariff refunds. Hanshow Technology's wholly-owned subsidiary in the United States has cumulatively received US tariff and interest refunds totaling 23.1064 million US dollars, equivalent to approximately 157 million yuan. After withholding, the impact on the company's 2026 net profit is approximately 71.1716 million yuan, accounting for 15.75% of the most recent audited net profit. Leyard's consolidated subsidiaries have cumulatively received US tariff and interest refunds totaling 16.5598 million US dollars, equivalent to approximately 112 million yuan. The specific impact on 2026 performance remains to be confirmed. Sirio Pharma's overseas subsidiaries have cumulatively received tariff and interest refunds totaling 11.7029 million US dollars, equivalent to approximately 79.4436 million yuan. Rongjie Health's controlled subsidiaries have cumulatively received 7.252 million US dollars, with an expected impact on the company's net profit attributable to the parent of 17.9599 million yuan, accounting for 24% of the most recent audited net profit. Shanghai Jahwa's wholly-owned overseas subsidiary has cumulatively received tariff and interest refunds of 4.6636 million US dollars, equivalent to approximately 32.322 million yuan, accounting for 12.08% of the company's most recent audited net profit. CFMOTO's wholly-owned subsidiary has cumulatively received US tariff and interest refunds of 38.6079 million US dollars, equivalent to 262 million yuan, with an expected impact on 2026 net profit of approximately 183 million yuan, accounting for 10.95% of the most recent audited net profit. Healthcare Co., Ltd.'s consolidated subsidiaries have cumulatively received US tariff refunds of 2.1324 million US dollars, equivalent to approximately 14.4764 million yuan, to be included in 2026 current profit or loss.
证券时报·8dRead more ▾
603313.CG2

Mlily subsidiary receives cumulative US tariff refunds and interest of 2.1324 million US dollars

Mlily announced that its consolidated subsidiaries have cumulatively received US tariff refunds and interest totaling 2.1324 million US dollars, equivalent to approximately 14.4764 million yuan. The refunds stem from the US Supreme Court ruling in February 2026 that the US government lacked statutory authority to impose tariffs under the International Emergency Economic Powers Act, rendering the relevant tariff measures void from the outset and requiring full refunds of collected tariffs plus interest. The US Customs and Border Protection officially began processing refunds on April 20, 2026. Of the amounts received by the company, the tariff portion was 2.04 million US dollars and the interest portion was 92,400 US dollars. The refunds are expected to be recognized in the company's current-period profit or loss for 2026 and do not involve adjustments to prior-year profit or loss.
中国证券报·13dRead more ▾
603313.CG

Mengbaihe Receives Approximately 14.48 Million Yuan in US Tariff Refunds

Mengbaihe announced that its consolidated subsidiaries have cumulatively received US tariff refunds totaling 2,132,399.42 US dollars, equivalent to approximately 14.48 million yuan. The above amount is planned to be recognized in the current period's profit or loss for 2026, and does not involve adjustments to prior years' profit or loss.
CLS·14dRead more ▾